{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:26:06Z","timestamp":1792513566560,"version":"4.5.0"},"reference-count":89,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T00:00:00Z","timestamp":1647734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Frequently silent until advanced stages, bone fragility associated with chronic kidney disease-mineral and bone disease (CKD-MBD) is one of the most devastating complications of CKD. Its pathophysiology includes the reduction of active vitamin D metabolites, phosphate accumulation, decreased intestinal calcium absorption, renal alpha klotho production, and elevated fibroblast growth factor 23 (FGF23) levels. Altogether, these factors contribute firstly to secondary hyperparathyroidism, and ultimately, to micro- and macrostructural bone changes, which lead to low bone mineral density and an increased risk of fracture. A vitamin D deficiency is common in CKD patients, and low circulating 25(OH)D levels are invariably associated with high serum parathyroid hormone (PTH) levels as well as with bone mineralization defects, such as osteomalacia in case of severe forms. It is also associated with a variety of non-skeletal diseases, including cardiovascular disease, diabetes mellitus, multiple sclerosis, cancer, and reduced immunological response. Current international guidelines recommend supplementing CKD patients with nutritional vitamin D as in the general population; however, there is no randomized clinical trial (RCT) evaluating the effect of vitamin D (or vitamin D+calcium) supplementation on the risk of fracture in the setting of CKD. It is also unknown what level of circulating 25(OH)D would be sufficient to prevent bone abnormalities and fractures in these patients. The impact of vitamin D supplementation on other surrogate endpoints, including bone mineral density and bone-related circulating biomarkers (PTH, FGF23, bone-specific alkaline phosphatase, sclerostin) has been evaluated in several RTCs; however, the results were not always translated into an improvement in long-term outcomes, such as reduced fracture risk. This review provides a brief and comprehensive update on CKD-related bone fragility and the use of natural vitamin D supplementation in these patients.<\/jats:p>","DOI":"10.3390\/metabo12030266","type":"journal-article","created":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T21:34:27Z","timestamp":1647812067000},"page":"266","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Bone Fragility in Chronic Kidney Disease Stage 3 to 5: The Use of Vitamin D Supplementation"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6757-1906","authenticated-orcid":false,"given":"Pablo Antonio","family":"Ure\u00f1a Torres","sequence":"first","affiliation":[{"name":"Department of Dialysis AURA Nord Saint Ouen, 12, Rue Anselme, 93400 Saint Ouen, France"},{"name":"Department of Renal Physiology, Necker Hospital, University of Paris Descartes, 75015 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Claude","family":"Souberbielle","sequence":"additional","affiliation":[{"name":"Department of Renal Physiology, Necker Hospital, University of Paris Descartes, 75015 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8582-8258","authenticated-orcid":false,"given":"Martine Cohen","family":"Solal","sequence":"additional","affiliation":[{"name":"Bioscar INSERM U1132, Department of Rheumatology, Universit\u00e9 de Paris, H\u00f4pital Lariboisi\u00e8re, 75010 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2215\/CJN.09500916","article-title":"Fractures in Patients with CKD: Time for Action","volume":"11","author":"Moe","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/ki.2013.547","article-title":"The three-year incidence of fracture in chronic kidney disease","volume":"86","author":"Naylor","year":"2014","journal-title":"Kidney Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1210\/jc.2013-1294","article-title":"Relation between circulating levels of 25(OH) vitamin D and parathyroid hormone in chronic kidney disease: Quest for a threshold","volume":"98","author":"Metzger","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1681\/ASN.2008020159","article-title":"Timing of onset of CKD-related metabolic complications","volume":"20","author":"Moranne","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_5","first-page":"822","article-title":"Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism","volume":"7","author":"Malberti","year":"1992","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ki.1997.41","article-title":"Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism","volume":"51","author":"Gogusev","year":"1997","journal-title":"Kidney Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ki.1973.92","article-title":"The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease","volume":"4","author":"Slatopolsky","year":"1973","journal-title":"Kidney Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1210\/en.2009-1160","article-title":"Minireview: The play of proteins on the parathyroid hormone messenger ribonucleic Acid regulates its expression","volume":"151","year":"2010","journal-title":"Endocrinology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/ndt\/gft514","article-title":"Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?","volume":"29","author":"Cozzolino","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_11","unstructured":"KDIGO (2009). KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int., 76, S1\u2013S130."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S2213-8587(17)30310-8","article-title":"Bone and mineral disorders in chronic kidney disease: Implications for cardiovascular health and ageing in the general population","volume":"6","author":"Covic","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00198-013-2435-1","article-title":"Incidence and risk factors for hip fractures in dialysis patients","volume":"25","author":"Maravic","year":"2014","journal-title":"Osteoporos. Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00198-015-3429-y","article-title":"Dementia is a major risk factor for hip fractures in patients with chronic kidney disease","volume":"27","author":"Maravic","year":"2016","journal-title":"Osteoporos. Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.kint.2017.07.021","article-title":"Fractures in patients with CKD-diagnosis, treatment, and prevention: A review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation","volume":"92","author":"Pimentel","year":"2017","journal-title":"Kidney Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.autrev.2010.06.009","article-title":"Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice","volume":"9","author":"Souberbielle","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000499187","article-title":"Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease","volume":"49","author":"Strugnell","year":"2019","journal-title":"Am. J. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.ekir.2021.03.874","article-title":"Longitudinal Bone Loss Occurs at the Radius in CKD","volume":"6","author":"Cailleaux","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1681\/ASN.2005111194","article-title":"Relationship between moderate to severe kidney disease and hip fracture in the United States","volume":"17","author":"Nickolas","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1093\/ndt\/gfg403","article-title":"Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients","volume":"18","author":"Urena","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/PHM.0000000000001254","article-title":"The Usefulness of Basic Movement Scale in Hip Fracture Patients: Construct Validity from a Cross-Sectional Study","volume":"98","author":"Goto","year":"2019","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/jbmr.4141","article-title":"Incidence of Fractures Before and After Dialysis Initiation","volume":"35","author":"Iseri","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2215\/CJN.06040614","article-title":"Comparison of fracture risk prediction among individuals with reduced and normal kidney function","volume":"10","author":"Naylor","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jbmr.5650040108","article-title":"Purification and characterization of human bone tartrate-resistant acid phosphatase","volume":"4","author":"Allen","year":"1989","journal-title":"J. Bone Miner. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bone.2003.10.001","article-title":"Fracture incidence and association with bone mineral density in elderly men and women: The Rotterdam Study","volume":"34","author":"Schuit","year":"2004","journal-title":"Bone"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0272-6386(96)90461-8","article-title":"Prevalence and risk factors for osteopenia in dialysis patients","volume":"28","author":"Stein","year":"1996","journal-title":"Am. J. Kidney Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.2215\/CJN.10370915","article-title":"Rates and Outcomes of Parathyroidectomy for Secondary Hyperparathyroidism in the United States","volume":"11","author":"Kim","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ki.2013.279","article-title":"Response to High rates of death and hospitalization follow bone fracture among hemodialysis patients","volume":"85","author":"Tentori","year":"2013","journal-title":"Kidney Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/ndt\/gfn678","article-title":"Chronic kidney disease and hip fracture-related mortality in older people in the UK","volume":"24","author":"Nitsch","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2215\/CJN.10901012","article-title":"Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States","volume":"8","author":"Nair","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ki.2012.19","article-title":"Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients","volume":"82","author":"Bhan","year":"2012","journal-title":"Kidney Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1210\/edrv-10-3-232","article-title":"The free hormone hypothesis: A physiologically based mathematical model","volume":"10","author":"Mendel","year":"1989","journal-title":"Endocr. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1096\/fj.06-6374fje","article-title":"Evidence for auto\/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells","volume":"20","author":"Koedam","year":"2006","journal-title":"FASEB J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mce.2011.05.024","article-title":"Vitamin D metabolism within bone cells: Effects on bone structure and strength","volume":"347","author":"Anderson","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/bonekey.2013.233","article-title":"Vitamin D: Direct effects of vitamin D metabolites on bone: Lessons from genetically modified mice","volume":"3","author":"Eisman","year":"2014","journal-title":"BoneKEy Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1172\/JCI98093","article-title":"Optimal bone fracture repair requires 24R,25-dihydroxyvitamin D3 and its effector molecule FAM57B2","volume":"128","author":"Martineau","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2011.05.031","article-title":"Vitamin D metabolism and activity in the parathyroid gland","volume":"347","author":"Bienaime","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000183383","article-title":"Serum concentrations of vitamin D metabolites in different degrees of impaired renal function. Estimation of renal and extrarenal secretion rate of 24,25-dihydroxyvitamin D","volume":"39","author":"Rickers","year":"1985","journal-title":"Nephron"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/j.ajkd.2011.04.029","article-title":"Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD","volume":"58","author":"Metzger","year":"2011","journal-title":"Am. J. Kidney Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1034\/j.1600-0560.2003.00109.x","article-title":"A current review of the cutaneous manifestations of renal disease","volume":"30","author":"Shalhub","year":"2003","journal-title":"J. Cutan. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1542-4758.2007.00186.x","article-title":"Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis","volume":"11","author":"Negri","year":"2007","journal-title":"Hemodial. Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000081023","article-title":"Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study","volume":"24","author":"Gonzalez","year":"2004","journal-title":"Am. J. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/jn\/114.7.1313","article-title":"Defective photoproduction of cholecalciferol in normal and uremic humans","volume":"114","author":"Jacob","year":"1984","journal-title":"J. Nutr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(73)92197-1","article-title":"Failure of formation of 1,25-dihydroxycholecalciferol in chronic renal insufficiency","volume":"1","author":"Mawer","year":"1973","journal-title":"Lancet"},{"key":"ref_46","first-page":"325","article-title":"Urinary excretion of 25-hydroxyvitamin D in health and the nephrotic syndrome","volume":"99","author":"Sato","year":"1982","journal-title":"J. Lab. Clin. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/ajcn\/37.3.403","article-title":"Impaired intestinal absorption of vitamin D3 in azotemic rats","volume":"37","author":"Vaziri","year":"1983","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0092-8674(00)80655-8","article-title":"An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3","volume":"96","author":"Nykjaer","year":"1999","journal-title":"Cell"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1523-1755.2003.00114.x","article-title":"Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats","volume":"64","author":"Takemoto","year":"2003","journal-title":"Kidney Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116720","article-title":"Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients","volume":"92","author":"Fukuda","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00041552-199507000-00003","article-title":"Altered vitamin D metabolism and receptor interaction with the target genes in renal failure: Calcitriol receptor interaction with its target gene in renal failure","volume":"4","author":"Hsu","year":"1995","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI118061","article-title":"Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins","volume":"96","author":"Patel","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: What\u2019s changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1210\/er.2018-00126","article-title":"Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions","volume":"40","author":"Bouillon","year":"2019","journal-title":"Endocr. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1053\/j.ajkd.2018.06.031","article-title":"The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation","volume":"72","author":"Melamed","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","article-title":"Vitamin D levels and patient outcome in chronic kidney disease","volume":"75","author":"Ravani","year":"2009","journal-title":"Kidney Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"288","DOI":"10.5414\/CNP64288","article-title":"Serum 25(OH)-vitamin D levels and bone metabolism in patients on maintenance hemodialysis","volume":"64","author":"Mucsi","year":"2005","journal-title":"Clin. Nephrol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ki.1979.25","article-title":"Comparison of 1\u03b1-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: Greater effect of 25-hydroxycholecalciferol on bone mineralization","volume":"15","author":"Fournier","year":"1979","journal-title":"Kidney Int."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/oxfordjournals.bmb.a069572","article-title":"Azotaemic renal osteodystrophy","volume":"13","author":"Stanbury","year":"1957","journal-title":"Br. Med. Bull."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11255-010-9723-x","article-title":"Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis","volume":"43","author":"Ambrus","year":"2011","journal-title":"Int. Urol. Nephrol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/j.1523-1755.2005.00603.x","article-title":"25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy","volume":"68","author":"Coen","year":"2005","journal-title":"Kidney Int."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00198-015-3386-5","article-title":"Calcium plus vitamin D supplementation and risk of fractures: An updated meta-analysis from the National Osteoporosis Foundation","volume":"27","author":"Weaver","year":"2016","journal-title":"Osteoporos. Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(18)30265-1","article-title":"Effects of vitamin D supplementation on musculoskeletal health: A systematic review, meta-analysis, and trial sequential analysis","volume":"6","author":"Bolland","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e10567","DOI":"10.1002\/jbm4.10567","article-title":"Vitamin D: Bolus Is Bogus-A Narrative Review","volume":"5","author":"Mazess","year":"2021","journal-title":"JBMR Plus"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S2213-8587(18)30348-6","article-title":"Vitamin D supplementation and musculoskeletal health","volume":"7","author":"Orav","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1007\/s00198-011-1868-7","article-title":"The 25(OH)D level needed to maintain a favorable bisphosphonate response is \u226533 ng\/mL","volume":"23","author":"Carmel","year":"2012","journal-title":"Osteoporos. Int."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40620-017-0404-z","article-title":"Osteoporosis, bone mineral density and CKD-MBD: Treatment considerations","volume":"30","author":"Bover","year":"2017","journal-title":"J. Nephrol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5414\/CN107180","article-title":"The effect of combined calcium and cholecalciferol supplementation on bone mineral density in elderly women with moderate chronic kidney disease","volume":"77","author":"Bosworth","year":"2012","journal-title":"Clin. Nephrol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jbmr.4469","article-title":"Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial","volume":"37","author":"Tsujita","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/08860220801964210","article-title":"Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients","volume":"30","author":"Dogan","year":"2008","journal-title":"Ren. Fail."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4158\/EP.14.1.10","article-title":"Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: A randomized controlled pilot study","volume":"14","author":"Chandra","year":"2008","journal-title":"Endocr. Pract."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.clnu.2016.05.012","article-title":"Vitamin D3 supplementation, bone health and quality of life in adults with diabetes and chronic kidney disease: Results of an open label randomized clinical trial","volume":"36","author":"Mager","year":"2017","journal-title":"Clin. Nutr."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/jbmr.3314","article-title":"The Effect of Vitamin D Supplementation on Bone Metabolic Markers in Chronic Kidney Disease","volume":"33","author":"Yadav","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jsbmb.2018.01.007","article-title":"Effect of vitamin D supplementation on serum sclerostin levels in chronic kidney disease","volume":"180","author":"Yadav","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00223-021-00844-1","article-title":"Vitamin D Supplementation for Patients with Chronic Kidney Disease: A Systematic Review and Meta-analyses of Trials Investigating the Response to Supplementation and an Overview of Guidelines","volume":"109","author":"Christodoulou","year":"2021","journal-title":"Calcif. Tissue Int."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.03940510","article-title":"Vitamin D supplementation in chronic kidney disease: A systematic review and meta-analysis of observational studies and randomized controlled trials","volume":"6","author":"Kandula","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/ckj\/sfab035","article-title":"Impact of nutritional vitamin D supplementation on parathyroid hormone and 25-hydroxyvitamin D levels in non-dialysis chronic kidney disease: A meta-analysis","volume":"14","author":"Bover","year":"2021","journal-title":"Clin. Kidney J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2215\/CJN.10791016","article-title":"Randomized Controlled Trial for the Effect of Vitamin D Supplementation on Vascular Stiffness in CKD","volume":"12","author":"Levin","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1159\/000369939","article-title":"Modified-release calcifediol effectively controls secondary hyperparathyroidism associated with vitamin D insufficiency in chronic kidney disease","volume":"40","author":"Sprague","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000450766","article-title":"Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease","volume":"44","author":"Sprague","year":"2016","journal-title":"Am. J. Nephrol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","article-title":"Calcium plus vitamin D supplementation and the risk of fractures","volume":"354","author":"Jackson","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1809944","article-title":"Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease","volume":"380","author":"Manson","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1900906","article-title":"Vitamin D Supplementation and Prevention of Type 2 Diabetes","volume":"381","author":"Pittas","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/ajcn\/nqy378","article-title":"Monthly high-dose vitamin D supplementation does not increase kidney stone risk or serum calcium: Results from a randomized controlled trial","volume":"109","author":"Malihi","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Bargagli, M., Ferraro, P.M., Vittori, M., Lombardi, G., Gambaro, G., and Somani, B. (2021). Calcium and Vitamin D Supplementation and Their Association with Kidney Stone Disease: A Narrative Review. Nutrients, 13.","DOI":"10.3390\/nu13124363"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1002\/ptr.7139","article-title":"The effect of vitamin D supplementation on fibroblast growth factor-23 in patients with chronic kidney disease: A systematic review and meta-analysis","volume":"35","author":"Karimi","year":"2021","journal-title":"Phytother. Res."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/12\/3\/266\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:39:49Z","timestamp":1760135989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/12\/3\/266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,20]]},"references-count":89,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["metabo12030266"],"URL":"https:\/\/doi.org\/10.3390\/metabo12030266","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,20]]}}}